Brief: Kiromic Biopharma Announced On Dec 16 Submission Of Two Investigational New Drug Applications With U.S. FDA
17/12/2020 16:32
Dec 17 (Reuters) - Kiromic Biopharma Inc KRBP.O :
* KIROMIC BIOPHARMA - ANNOUNCED ON DEC 16 SUBMISSION OF TWO
INVESTIGATIONAL NEW DRUG APPLICATIONS WITH U.S. FDA
* KIROMIC BIOPHARMA- IND APPLICATION FOR INITIATION OF PHASE
1
CLINICAL TRIAL OF IV ADMINISTERED ALLOGENIC CAR-T FOR EOC,
MALIGNANT PLEURAL MESOTHELIOMA
* KIROMIC BIOPHARMA - IND APPLICATION FOR INITIATION OF
PHASE 1
CLINICAL TRIAL OF IP ADMINISTERED ALLOGENIC CAR-T FOR EOC AND
MPM
Source text: [https://bit.ly/3mv0YT2]
Further company coverage: KRBP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kiromic Biopharma
See all newsBrief: Kiromic Biopharma Files For Offering Up To 1 Million Units
Brief: Kiromic Biopharma Applies To List Common Stock On The NYSE American Under Symbol 'KRBP'
Brief: Kiromic Biopharma Advances Deltacel-01 Into Expansion Phase Following Safety Monitoring Committee's Unanimous Recommendation
Brief: Kiromic Biopharma Reports Favorable Results At Six Weeks From Fourth Patient In Deltacel-01 Clinical Trial
Brief: Kiromic BioPharma Adds UPMC as Fourth Deltacel-01 Clinical Trial Site